ES2170403T3 - Derivados de n-bencil-piperidina y tetrahidro-piridina. - Google Patents

Derivados de n-bencil-piperidina y tetrahidro-piridina.

Info

Publication number
ES2170403T3
ES2170403T3 ES97932953T ES97932953T ES2170403T3 ES 2170403 T3 ES2170403 T3 ES 2170403T3 ES 97932953 T ES97932953 T ES 97932953T ES 97932953 T ES97932953 T ES 97932953T ES 2170403 T3 ES2170403 T3 ES 2170403T3
Authority
ES
Spain
Prior art keywords
compounds
group
preparation
isomeros
paroxetine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97932953T
Other languages
English (en)
Inventor
Janos Kreidl
Laszlo Czibula
Andras Nemes
Juhasz Ida Deutschne
Papp Eva Werkne
Bagdy Judit Nagyne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Application granted granted Critical
Publication of ES2170403T3 publication Critical patent/ES2170403T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA (I), DONDE X REPRESENTA UN GRUPO HIDROXILO, UN HALOGENO O UN GRUPO R - SO 3 -, DONDE R REPRESENTA UN GRUPO ARILO O ALQUILO OPCION ALMENTE SUSTITUIDO; A Y B REPRESENTAN CADA UNO HIDROGENO, O A Y B CONJUNTAMENTE PUEDEN FORMAR ENLACE DE VALENCIA; ASI COMO ISOMEROS CIS Y TRANS, ENANTIOMEROS OPTICAMENTE ACTIVOS Y RACEMATOS DE LOS MISMOS, Y LAS SALES DE DICHOS COMPUESTOS. LOS NUEVOS COMPUESTOS DE FORMULA (I) DE LA INVENCION SON INTERMEDIARIOS VALIOSOS PARA LA PREPARACION DE PAROXETINA, UN MEDICAMENTO ANTIDEPRESIVO. ADEMAS, LA INVENCION SE REFIERE A UN PROCEDIMIENTO DE PREPARACION DE LOS NUEVOS COMPUESTOS DE FORMULA (I), DONDE X, R, A Y B SON TAL Y COMO SE LOS DEFINIO ANTERIORMENTE, ASI COMO ISOMEROS CIS Y TRANS, ENANTIOMEROS OPTICAMENTE ACTIVOS Y RACEMATOS DE LOS MISMOS Y LAS SALES DE DICHOS COMPUESTOS. POR ULTIMO, SE DESCRIBE LA UTILIZACION DE DICHAS SUSTANCIAS PARA LA PREPARACION DE PAROXETINA DE FORMULA (V).
ES97932953T 1996-07-08 1997-07-07 Derivados de n-bencil-piperidina y tetrahidro-piridina. Expired - Lifetime ES2170403T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9601857A HU221921B1 (hu) 1996-07-08 1996-07-08 N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására

Publications (1)

Publication Number Publication Date
ES2170403T3 true ES2170403T3 (es) 2002-08-01

Family

ID=89994099

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97932953T Expired - Lifetime ES2170403T3 (es) 1996-07-08 1997-07-07 Derivados de n-bencil-piperidina y tetrahidro-piridina.

Country Status (10)

Country Link
US (1) US6657062B1 (es)
EP (1) EP0923554B1 (es)
AT (1) ATE211732T1 (es)
AU (1) AU3631197A (es)
DE (1) DE69709938T2 (es)
DK (1) DK0923554T3 (es)
ES (1) ES2170403T3 (es)
HU (1) HU221921B1 (es)
PT (1) PT923554E (es)
WO (1) WO1998001424A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9710004D0 (en) 1997-05-17 1997-07-09 Knoll Ag Chemical process
AU3108097A (en) 1997-06-10 1998-12-30 Synthon B.V. 4-phenylpiperidine compounds
CA2319652A1 (en) * 1998-02-06 1999-08-12 Michael Urquhart Salts of paroxetine
GB9808894D0 (en) * 1998-04-25 1998-06-24 Smithkline Beecham Plc Novel compound
GB9814316D0 (en) * 1998-07-02 1998-09-02 Smithkline Beecham Plc Novel compounds
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
WO2000008016A1 (en) * 1998-08-08 2000-02-17 Smithkline Beecham Plc Paroxetine salts
DK1135383T3 (da) * 1998-11-30 2004-04-05 Smithkline Beecham Plc Blandede paroxetin-propan-2-ol-solvater
GB9826171D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel compounds
GB9826242D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9826178D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9828780D0 (en) * 1998-12-29 1999-02-17 Smithkline Beecham Plc Novel process
IT1308629B1 (it) * 1999-02-23 2002-01-09 Recordati Chem Pharm Processo per la produzione di paroxetina.
GB9916187D0 (en) * 1999-07-09 1999-09-08 Smithkline Beecham Plc Novel process
IT1313702B1 (it) * 1999-08-02 2002-09-09 Chemi Spa Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piperidine.
GB9919052D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel compound composition and process
GB9920146D0 (en) * 1999-08-25 1999-10-27 Smithkline Beecham Plc Novel process
GB9923539D0 (en) * 1999-10-05 1999-12-08 Smithkline Beecham Plc Novel process
GB9923540D0 (en) * 1999-10-05 1999-12-08 Smithkline Beecham Plc Novel process
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
CZ20023694A3 (cs) 2000-05-12 2003-05-14 Synthon B. V. Tosylátové soli 4-(p-fluorfenyl)-piperidin-3-methanolů
EP1286965B1 (en) * 2000-05-12 2004-01-14 Synthon B.V. Piperidine compounds and process for providing such
GB0021145D0 (en) * 2000-08-30 2000-10-11 Knoll Ag Chemical process
GB0021147D0 (en) * 2000-08-30 2000-10-11 Knoll Ag Chemical process
US6777554B2 (en) * 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
IL159280A0 (en) * 2001-06-14 2004-06-01 Teva Pharma A process for preparing paroxetine hcl which limits formation of pink colored compounds
GB2382074A (en) 2001-11-14 2003-05-21 Basf Ag Recovery of chiral tartaric acid resolving agents
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
CH583730A5 (es) * 1973-09-25 1977-01-14 Wander Ag Dr A
DE3242923A1 (de) * 1982-11-20 1984-05-24 Basf Ag, 6700 Ludwigshafen 7-phenyl-7-phenoxymethyl-hexahydro-1,4-oxazepine, ihre herstellung und verwendung
US4585777A (en) * 1984-02-07 1986-04-29 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT
EP0190496A3 (en) 1984-12-13 1987-05-27 Beecham Group Plc Piperidine derivatives having a gastro-intestinal activity
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
HUP9900318A3 (en) * 1995-05-17 2001-09-28 Novo Nordisk As Process for preparing 4-aryl-piperidine derivatives
RU2167865C2 (ru) 1995-09-07 2001-05-27 Ф. Хоффманн-Ля Рош Аг Производные пиперидина, способ их получения, фармацевтическая композиция на их основе и промежуточные вещества
GB9526645D0 (en) * 1995-12-28 1996-02-28 Chiroscience Ltd Stereoselective synthesis
AU3108097A (en) * 1997-06-10 1998-12-30 Synthon B.V. 4-phenylpiperidine compounds

Also Published As

Publication number Publication date
DK0923554T3 (da) 2002-04-29
US6657062B1 (en) 2003-12-02
HU9601857D0 (en) 1996-08-28
EP0923554B1 (en) 2002-01-09
ATE211732T1 (de) 2002-01-15
HU221921B1 (hu) 2003-02-28
AU3631197A (en) 1998-02-02
HUP9601857A2 (hu) 1998-05-28
WO1998001424A1 (en) 1998-01-15
HUP9601857A3 (en) 1998-07-28
PT923554E (pt) 2002-07-31
EP0923554A1 (en) 1999-06-23
DE69709938D1 (de) 2002-02-28
DE69709938T2 (de) 2002-08-29

Similar Documents

Publication Publication Date Title
ES2170403T3 (es) Derivados de n-bencil-piperidina y tetrahidro-piridina.
MX9600484A (es) Anhidrato de clorhidrato de paroxetina y procedimiento para su preparacion.
ES542320A0 (es) Un procedimiento para la preparacion de derivados de la 2 pirimidinil 1 piperazina
ES2059207T3 (es) Procedimiento para la preparacion de derivados del taxano, nuevos derivados obtenidos y composiciones farmaceuticas que les contienen.
ECSP941096A (es) Procedimiento para la preparacion de un derivado indol
ES557359A0 (es) Un procedimiento para preparar derivados de piperazina
AR001332A1 (es) Nuevos compuestos antagonistas de la taquicinina, proceso para obtenerlos y composiciones farmaceuticas que los contienen.
ES507142A0 (es) Un procedimiento para la preparacion del enantiomero (-) de la n-metil-3-(2metilfenoxi)-3-fenilpropilamina.
FI961809A0 (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
MX9300786A (es) Compuestos hipolipidaemicos.
ES2001152A4 (es) Preparados cosmeticos a base de n - hidroxibutil - quitosanas, nuevasn - hidroxibutil - quitosanas, asi como el procedimiento para su obtencion.
FI860842A0 (fi) Labdan-derivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
NO910868D0 (no) Antiglaukompreparater inneholdende 3-arylkarbonyl-1-aminoalkyl-1h-indol og fremgangsmaate for fremstilling derav.
ES2159922T3 (es) Nuevos derivados de bencimidazol, de benzoxazol y de benzotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES506584A0 (es) Procedimiento para la preparacion de derivados de isoquino- leina
DE3770487D1 (de) Karboxyliertes oberflaechenaktives mittel enthaltende schmiermittel, deren herstellung und verwendung.
ES2195852T3 (es) Nuevas bases de oxidacion cationicas, su utilizacion para el teñido por oxidacion de las fibras queratinicas, composiciones tintoreas y procedimientos de teñido.
ES512533A0 (es) Un procedimiento para la preparacion de 1-(3-halo-2-piridinil)piperazinas.
ATE67495T1 (de) 4-(1,2,5,6-tetrahydro-1-alkyl-3-pyridinyl)-2thiazolamine und 4-(hexahydro-1-alkyl-3pyridinyl)-2-thiazolamine.
AR001813A1 (es) Derivados de cromona procedimiento para prepararlos y las composiciones farmacéutica que los contienen
ES2058854T3 (es) Composiciones y procedimientos de tincion que emplean como copuladores derivados de 6- o 7-hidroxiindol.
ES2091509T3 (es) Procedimiento para la obtencion de derivados de isopreno.
DK0871446T3 (da) Anvendelse af eliprodil til fremstilling af et lægemiddel til behandling af ischaemiske sygdomme i nethinden eller den optiske nerve
SE8404334L (sv) 16-fluoro-16,17-didehydro-prostanoider och forfarande for deras framstellning
ES2187783T3 (es) Derivados de indolina utiles como antagonistas del receptor 5-ht-2c.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 923554

Country of ref document: ES